The global race for innovation The world of innovation is not “flat”. The attention of global "innovation hunters" (VC funds, large corporates, etc.) today tends to gravitate toward a selected few global hotspots distinguished by a high density of scaleups, capital, and talent: Silicon Valley, Israel, and probably less than another dozen of hubs across [...]
Un muy buen resumen de un gran informe. Origen: Las tech en crecimiento: 100.000 empleos y 11.541 M€ de ventas El ecosistema emprendedor español más de 7.028 compañías tecnológicas activas, 3.640 son start-ups (menos de cinco años de actividad) 1.185 son scaleups (facturan más de un millón de euros) el resto PYMES han vendido [...]
En su newsletter, el Parque Científico de la Universidad de Valencia informaba de la reciente publicación de la "Orden PCM/825/2023, de 20 de julio, por la que se regulan los criterios y el procedimiento de certificación de empresas emergentes que dan acceso a los beneficios y especialidades reconocidas en la Ley 28/2022, de 21 de [...]
The reason VC’s are gaining ESG altitude is simple: institutional investors and family offices are now leaning in. Origen: Solving VC’s ESG Puzzle. Upstream investment strategy remains… | by Gabe Kleinman | May, 2021 | World Positive Environmental, Social, and Governance (“ESG”) standards are having a moment with climate change (and climate risk), broad socioeconomic [...]
Todos sabemos que la valoración no es la única ni quizás la mejor métrica para definir el éxito de una empresa. Pero, ante la ausencia de datos sobre ingresos, beneficios o impacto social, parece un proxy razonable. Samuel resume magníficamente, no te pierdas sus conclusiones, el libro Super Founders: What Data Reveals About Billion-Dollar Startups de [...]
…or chief of stuff. someone to come in and fix things Creating new names is something startups and innovators do often. Chief of staff is: the only role other than the COO that’s really cross-functional an enabler for the CEO “helicoptering” into whatever needs to be done and helping to solve problems —that don’t necessarily [...]
Cultivating an understanding of the VC investment landscape of US-based biotech & pharma startups. Origin: PitchBook Analyst Note: Betting on Biotech Key takeaways: Over the last few decades, the biotechnology & pharmaceuticals (biotech & pharma) industry has seen a shift from drug development through internal R&D efforts at large-cap public incumbents to an M&A-based model. The drug [...]
The ability to iterate on something until it works is underrated. …a PM who’s taken a product from version two to eight at a smaller startup, vs. someone who’s worked at scale, but only shipped initial versions and then moved on. Origen: The Phases Product Teams Go Through, From Product/Market Fit to Hypergrowth | First [...]
–Early revenue growth isn’t always a positive —instead, focus on market fit— –Growth isn’t always worth it Origen: 11 Lessons From Venture Capitalist Fred Wilson - CB Insights Research Product development Keep your vision simple at the beginning Early revenue growth isn’t always a positive — instead, focus on market fit “A hard charging sales [...]
& I'd dare to say that more competition is also on the way. Markets are bigger and faster than ever before. In general, software markets and businesses are 10X bigger than they were 10-15 years ago. This is due to the liquidity provided by the global internet. A company that would have been a $10-$20M [...]